More N95 Masks Are On The Way As Production Ramps Up Into 2021

The CEO of 3M, Mike Roman, announced that production of its N95 respirator masks is increasing since COVID-19 is starting to become more widespread in many countries. 

3M, a company focused on the industry field, health care, consumer goods and worker safety, started producing more of the N95 masks in January when China’s cases began to skyrocket and before the coronavirus pandemic made its way to the US.

The company is slated to produce around 2 billion masks by the end of the year, Roman explained to CNBC. Half of those masks will be used in the US. 

“We are bringing capacity on. We are making more N95 respirators than ever, and we’ll continue to add some capacity as we go into the end of the year, into next year,” Roman also added. 

These specific types of masks are mainly needed by those in the healthcare field and those who are first responders. 

There have been shortages of these masks and other PPE throughout the entire pandemic. Experts stress that the general public shouldn’t be wearing these specific masks. This way, there’ll be more for those who have to wear them daily, according to CNBC. 

For those that prefer to wear N95’s, Roman explained, “We’ll continue to look for ways to support consumers, and our consumer teams are looking at innovative, new mask kinds of solutions in addition to the N95 respirators, so we’ll work to respond to that, as well.”

The general public should wear cloth face coverings/masks in order to protect themselves and others from the virus, per CDC recommendations.

N95Masks A Brooklyn man was arrested for selling medical supplies at inflated prices. Photo: Creative Commons

Source Article

Read more

Amid Growing Customer Demand, ADM Invests to Significantly Expand Probiotics Production

State-of-the-art expansion represents five-fold increase in probiotics production capacity

ADM (NYSE: ADM) announced today that it plans to construct a new, state-of-the-art facility in Valencia, Spain, that will expand its capabilities to meet growing demand for microbiome solutions.

“Our new Valencia facility will feature leading-edge technology and dramatically enhance our ability to meet fast-growing demand for products and solutions from nature designed to target the microbiome and help improve metabolic health,” said Ian Pinner, chief strategy and innovation officer, and president of ADM’s Health & Wellness division. “Consumers today are increasingly focusing on the foundational role food plays in supporting health and wellness, and our continued investment in these growth areas ensures that ADM is perfectly positioned to meet their needs.”

The new facility represents a five-fold increase in production capacity through ADM’s Biopolis, a leading provider of microbial technologies based in Spain. The facility will produce a wide array of science-based, innovative probiotics and postbiotics — using ADM’s industry-leading technology — to meet growing demand for new solutions for healthy weight management, skin health, immune health, gut health, oral health, fertility and more. It will be co-located with ADM’s flavor production facility in Valencia, and is expected to be online in 2022.

“Consumers today are thinking about the things they eat and drink in entirely new ways,” Pinner continued. “They expect food and beverages that are not only delicious, but support health and wellness, come from sustainable ingredients, and are produced by companies that share their values. The growth investments ADM has made in recent years put us in an unparalleled position to meet those changing needs. From alternative proteins, to our pantry of sustainable ingredients, flavors and colors, to our unequalled array of pre-, pro- and postbiotics, ADM is enriching lives around the globe.”

ADM is an established market leader for microbiome solutions with an award-winning portfolio of products and ingredients, including NutraIngredients’ 2020 ‘Probiotic Product of the Year’, ADM’s Bio-Kult Migréa®; 2020 Ingredient of the Year in the Weight Management category, ADM’s Bifidobacterium lactis BPL1; and the 2020 Editor’s Award winner for Functional Food Innovation, ADM’s Bacillus subtilis PXN®21®, a live microbial strain shown to reduce the aggregation of α-synuclein, paving the way for future research in Parkinson’s disease.

For more information about ADM’s functional health solutions, visit www.adm.com/functionalhealth.

About ADM

At ADM, we unlock the power of nature to provide access to nutrition worldwide. With industry-advancing innovations, a complete portfolio of ingredients and solutions to meet any taste, and a commitment to sustainability, we give customers an edge in solving the nutritional challenges of today and tomorrow. We’re a global leader in human and animal nutrition and the world’s premier agricultural origination and processing company. Our breadth, depth, insights, facilities and logistical expertise give us unparalleled capabilities to meet needs for food, beverages, health and wellness, and more. From the seed of the idea to the outcome of the solution, we enrich the quality of life the world over. Learn more at www.adm.com.

Source:

Read more